<VariationArchive RecordType="classified" VariationID="11588" VariationName="NC_000023.11:g.(154776372_154776374)_(154778317_154778319)del" VariationType="Deletion" Accession="VCV000011588" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2017-12-15" MostRecentSubmission="2017-12-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26627" VariationID="11588">
      <GeneList>
        <Gene Symbol="DKC1" FullName="dyskerin pseudouridine synthase 1" GeneID="1736" HGNC_ID="HGNC:2890" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="154762864" stop="154777689" display_start="154762864" display_stop="154777689" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="153991030" stop="154005963" display_start="153991030" display_stop="154005963" Strand="+" />
          </Location>
          <OMIM>300126</OMIM>
          <Haploinsufficiency last_evaluated="2012-04-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DKC1">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-04-25" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DKC1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.(154776372_154776374)_(154778317_154778319)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" outerStart="154776372" innerStart="154776374" innerStop="154778317" outerStop="154778319" display_start="154776372" display_stop="154778319" variantLength="1944" Strand="+" />
      </Location>
      <OtherNameList>
        <Name>2-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(154776372_154776374)_(154778317_154778319)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(154776372_154776374)_(154778317_154778319)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="nssv1415036" DB="dbVar" />
        <XRef ID="nsv513808" DB="dbVar" />
        <XRef Type="Allelic variant" ID="300126.0007" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 10438713 Fig. 1 to determine the location of this allele on the current reference sequence. </Comment>
      <Comment DataSource="NCBI curation" Type="public">2-kb deletion spanning the last exon of DKC1 plus flanking intronic sequences.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.(154776372_154776374)_(154778317_154778319)del AND Dyskeratosis congenita, X-linked" Accession="RCV000012345" Version="23">
        <ClassifiedConditionList TraitSetID="3163">
          <ClassifiedCondition DB="MedGen" ID="C1148551">Dyskeratosis congenita, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-08-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1999-08-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-12-15" MostRecentSubmission="2017-12-15">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10438713</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3163" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1509" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Zinsser-Cole-Engman Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, X-linked</ElementValue>
                <XRef ID="MONDO:0010584" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DKCX</ElementValue>
                <XRef Type="MIM" ID="305000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DKC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2007" />
                <XRef ID="2007" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21610750</ID>
              </Citation>
              <XRef ID="C1148551" DB="MedGen" />
              <XRef ID="MONDO:0010584" DB="MONDO" />
              <XRef Type="MIM" ID="305000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32579" SubmissionDate="2017-12-11" DateLastUpdated="2017-12-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300126.0007_DYSKERATOSIS CONGENITA, X-LINKED" title="DKC1, 2-KB DEL_DYSKERATOSIS CONGENITA, X-LINKED" />
        <ClinVarAccession Accession="SCV000032579" DateUpdated="2017-12-15" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-08-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Vulliamy et al. (1999) presented a case of dyskeratosis congenita (305000) caused by a 2-kb deletion that removed the last exon of the DKC1 gene. Normal levels of mRNA were produced from the deleted gene, with the transcripts using a cryptic polyadenylation site in the antisense strand of the adjacent MPP1 gene (305360), which is normally located 1 kb downstream of DKC1 in a tail-to-tail orientation. The predicted truncated protein lacked a lysine-rich peptide that is less conserved than the rest of the dyskerin molecule and is dispensable in yeast, supporting the contention that it may retain some activity and that null mutations at this locus may be lethal. The affected boy had an unaffected brother with the same haplotype around the DKC1 gene and a sister who was heterozygous for the deletion. The authors concluded, therefore, that the mother must be a germline mosaic with respect to this deletion. Investigation of her blood cells and other somatic tissues showed that a small proportion of these cells also carried the deletion, making her a somatic mosaic and indicating that the deletion took place early in development.</Attribute>
              <Citation>
                <ID Source="PubMed">10438713</ID>
              </Citation>
              <XRef DB="OMIM" ID="305000" Type="MIM" />
              <XRef DB="OMIM" ID="305360" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DKC1" />
          </GeneList>
          <Name>DKC1, 2-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300126.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DYSKERATOSIS CONGENITA, X-LINKED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32579" TraitType="Disease" MappingType="Name" MappingValue="DYSKERATOSIS CONGENITA, X-LINKED" MappingRef="Preferred">
        <MedGen CUI="C1148551" Name="Dyskeratosis congenita, X-linked" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

